Latest Articles

Publication Date
Evaluating the association between lipidome and female reproductive diseases through comprehensive Mendelian randomization analyses.

This study aimed to assess the causal relationship between lipidome and female reproductive diseases (FRDs) using an advanced series of Mendelian randomization (MR) methods. This study utilized genome-wide association study …

Published: Jan. 19, 2025, midnight
Selective progesterone receptor modulators for the treatment of dysmenorrhea: an update.

Dysmenorrhea is a painful symptom associated with uterine contractions and menstrual bleeding and is treated by administering analgesic drugs. Since progesterone receptors (PRs) have a major role in regulating uterine …

Published: Jan. 14, 2025, midnight
Hair Relaxer Uterine Fibroids Lawsuit - Lawsuit Information Center Blog

Hair Relaxer Uterine Fibroids Lawsuit Lawsuit Information Center Blog

Published: Jan. 6, 2025, 11 a.m.
GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy.

Overexpression of the gonadotropin-releasing hormone receptor (GnRH-R) plays a vital role in the advancement of reproductive malignancies such as ovarian, endometrial, and prostate cancer. Peptidomimetic GnRH antagonists are a substantial …

Published: Dec. 31, 2024, midnight
Women with Endometriosis and uterine fibroids likely to have Premature death, suggests study - Medical Dialogues

Women with Endometriosis and uterine fibroids likely to have Premature death, suggests study Medical Dialogues

Published: Dec. 25, 2024, 2:45 p.m.
Social Determinants of Health and Lifestyle Risk Factors Modulate Genetic Susceptibility for Women's Health Outcomes.

Women's health conditions are influenced by both genetic and environmental factors. Understanding these factors individually and their interactions is crucial for implementing preventative, personalized medicine. However, since genetics and environmental …

Published: Dec. 14, 2024, midnight
The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications.

In ovarian steroid-dependent diseases such as uterine fibroids, endometriosis and adenomyosis, oral GnRH antagonists have emerged as new therapeutic alternatives. These oral GnRH antagonists offer key advantages, including oral administration, …

Published: Dec. 12, 2024, midnight
Exploring Self-Reported Symptoms for Developing and Evaluating Digital Symptom Checkers for Polycystic Ovarian Syndrome, Endometriosis, and Uterine Fibroids: Exploratory Survey Study.

Reproductive health conditions such as polycystic ovary syndrome (PCOS), endometriosis, and uterine fibroids pose a significant burden to people who menstruate, health care systems, and economies. Despite clinical guidelines for …

Published: Dec. 12, 2024, midnight
National Utilization Trends of Inpatient Procedures for Symptomatic Uterine Fibroids and Adenomyosis: A 10-year Analysis.

To determine the changes in procedural utilization for symptomatic uterine fibroids and adenomyosis over the past decade.

Published: Dec. 9, 2024, midnight
Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers - Physician's Weekly

Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers Physician's Weekly

Published: Nov. 30, 2024, 10:44 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!